REX AI Equity Premium Income ETF vs Mesoblast Limited — how do they compare? REX AI Equity Premium Income ETF trades at $37.4, while Mesoblast Limited trades at $16.98 (market cap $2.21B). The key difference: Mesoblast Limited is trading nearer its 52-week high, REX AI Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.
| AIPI | MESO | |
|---|---|---|
Sector | Income / Options Overlay | Technology |
52-Week High | $44.93 | $20.96 |
52-Week Low | $32.45 | $12.88 |
Market Cap | — | $2.21B |
Enterprise Value | — | $2.21B |
Trailing returns across standard periods
AIPI provides exposure to leading artificial intelligence firms while seeking to generate monthly income. It uses a covered call strategy to capture premiums from the volatility of AI-related stocks.
Read more on AIPI →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →